7-44145489-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000162.5(GCK):​c.1253+8C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.215 in 1,592,264 control chromosomes in the GnomAD database, including 47,418 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.34 ( 11807 hom., cov: 34)
Exomes 𝑓: 0.20 ( 35611 hom. )

Consequence

GCK
NM_000162.5 splice_region, intron

Scores

2
Splicing: ADA: 0.0009073
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 0.451

Publications

25 publications found
Variant links:
Genes affected
GCK (HGNC:4195): (glucokinase) This gene encodes a member of the hexokinase family of proteins. Hexokinases phosphorylate glucose to produce glucose-6-phosphate, the first step in most glucose metabolism pathways. In contrast to other forms of hexokinase, this enzyme is not inhibited by its product glucose-6-phosphate but remains active while glucose is abundant. The use of multiple promoters and alternative splicing of this gene result in distinct protein isoforms that exhibit tissue-specific expression in the pancreas and liver. In the pancreas, this enzyme plays a role in glucose-stimulated insulin secretion, while in the liver, this enzyme is important in glucose uptake and conversion to glycogen. Mutations in this gene that alter enzyme activity have been associated with multiple types of diabetes and hyperinsulinemic hypoglycemia. [provided by RefSeq, Aug 2017]
GCK Gene-Disease associations (from GenCC):
  • hyperinsulinism due to glucokinase deficiency
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet
  • maturity-onset diabetes of the young type 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • monogenic diabetes
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • diabetes mellitus, noninsulin-dependent
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • permanent neonatal diabetes mellitus 1
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • transient neonatal diabetes mellitus
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
  • maturity-onset diabetes of the young
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • permanent neonatal diabetes mellitus
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.7).
BP6
Variant 7-44145489-G-A is Benign according to our data. Variant chr7-44145489-G-A is described in ClinVar as Benign. ClinVar VariationId is 129147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.651 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000162.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GCK
NM_000162.5
MANE Select
c.1253+8C>T
splice_region intron
N/ANP_000153.1Q53Y25
GCK
NM_033507.3
c.1256+8C>T
splice_region intron
N/ANP_277042.1P35557-2
GCK
NM_033508.3
c.1250+8C>T
splice_region intron
N/ANP_277043.1P35557-3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GCK
ENST00000403799.8
TSL:1 MANE Select
c.1253+8C>T
splice_region intron
N/AENSP00000384247.3P35557-1
GCK
ENST00000395796.8
TSL:1
n.*1251+8C>T
splice_region intron
N/AENSP00000379142.4A0A8C8KJG0
GCK
ENST00000459642.1
TSL:1
n.633+8C>T
splice_region intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.335
AC:
50947
AN:
152062
Hom.:
11776
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.658
Gnomad AMI
AF:
0.126
Gnomad AMR
AF:
0.283
Gnomad ASJ
AF:
0.169
Gnomad EAS
AF:
0.387
Gnomad SAS
AF:
0.301
Gnomad FIN
AF:
0.233
Gnomad MID
AF:
0.187
Gnomad NFE
AF:
0.178
Gnomad OTH
AF:
0.279
GnomAD2 exomes
AF:
0.270
AC:
59821
AN:
221712
AF XY:
0.259
show subpopulations
Gnomad AFR exome
AF:
0.672
Gnomad AMR exome
AF:
0.311
Gnomad ASJ exome
AF:
0.169
Gnomad EAS exome
AF:
0.433
Gnomad FIN exome
AF:
0.238
Gnomad NFE exome
AF:
0.183
Gnomad OTH exome
AF:
0.220
GnomAD4 exome
AF:
0.202
AC:
291080
AN:
1440084
Hom.:
35611
Cov.:
33
AF XY:
0.203
AC XY:
144864
AN XY:
713972
show subpopulations
African (AFR)
AF:
0.680
AC:
22521
AN:
33138
American (AMR)
AF:
0.306
AC:
13068
AN:
42712
Ashkenazi Jewish (ASJ)
AF:
0.170
AC:
4378
AN:
25818
East Asian (EAS)
AF:
0.389
AC:
15119
AN:
38880
South Asian (SAS)
AF:
0.283
AC:
23894
AN:
84386
European-Finnish (FIN)
AF:
0.238
AC:
11825
AN:
49644
Middle Eastern (MID)
AF:
0.212
AC:
1193
AN:
5620
European-Non Finnish (NFE)
AF:
0.169
AC:
185850
AN:
1100430
Other (OTH)
AF:
0.223
AC:
13232
AN:
59456
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
14579
29158
43738
58317
72896
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
6946
13892
20838
27784
34730
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.335
AC:
51020
AN:
152180
Hom.:
11807
Cov.:
34
AF XY:
0.337
AC XY:
25049
AN XY:
74402
show subpopulations
African (AFR)
AF:
0.658
AC:
27289
AN:
41490
American (AMR)
AF:
0.283
AC:
4330
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.169
AC:
586
AN:
3470
East Asian (EAS)
AF:
0.387
AC:
2000
AN:
5164
South Asian (SAS)
AF:
0.299
AC:
1445
AN:
4826
European-Finnish (FIN)
AF:
0.233
AC:
2475
AN:
10604
Middle Eastern (MID)
AF:
0.184
AC:
54
AN:
294
European-Non Finnish (NFE)
AF:
0.178
AC:
12137
AN:
68000
Other (OTH)
AF:
0.278
AC:
589
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1495
2990
4485
5980
7475
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
470
940
1410
1880
2350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.243
Hom.:
4273
Bravo
AF:
0.353
Asia WGS
AF:
0.330
AC:
1147
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
Maturity-onset diabetes of the young (2)
-
-
2
not provided (2)
-
-
2
not specified (2)
-
-
1
Hyperinsulinism due to glucokinase deficiency (1)
-
-
1
Maturity-onset diabetes of the young type 2 (1)
-
-
1
Permanent neonatal diabetes mellitus (1)
-
-
1
Transient Neonatal Diabetes, Recessive (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.70
CADD
Benign
6.8
DANN
Benign
0.95
PhyloP100
0.45
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00091
dbscSNV1_RF
Benign
0.0020
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2908274; hg19: chr7-44185088; COSMIC: COSV56267403; COSMIC: COSV56267403; API